Footnotes

[1] The term “Indian hemp” is used throughout the text in reference to Cannabis sativa L.. It should not be mistaken with Apocynum cannabinum L., an unrelated plant native to North America and also sometimes called “Indian hemp” or “black Indian hemp.” The word “hashish” is used indistinctively to refer to the Cannabis plant, its tops, or its resin. Generally, the terminology related to plants “is somewhat awkward” in these old treaties (Unification of Conventions…, 1950; see also LoN, 1935a, p. 33).
[2]  Communications with INCB, UN libraries in Geneva and Vienna, and Dag Hammarskjöld library. This is not particularly surprising, given INCB’s track-record of great secrecy (Csete, 2012; Fields of Green for All NPC, 2021) in a context where access to the documentation of intergovernmental organisations is often a complicated endeavour (Church and McCaffrey, 2013).
[3] This is sometimes translated as “International Office of Public Hygiene” or “International Public Health Bureau.” However, French was the only official language for all names and documents of the OIHP, since that language was at the times the hegemonic diplomatic language. The fact that only French-language versions of the work of OIHP are available may have contributed to their scare presence in the literature. In addition, the archives of the OIHP have had a convoluted history: evacuated from Paris and disseminated during WWI, partially lost, partly transferred at the WHO library in 1950 by decision of the third World Health Assembly (Resolution WHA3.98; WHO, 1950b, p. 59), subsequently de-catalogued by parts, split between various collections of archives, parts of which have been decatalogued: the few archives that survived is nowadays kept at the WHO library and LoN Archives, in Geneva.
[4] Until the mid-20th Century, most popular practices of day-to-day healthcare maintenance and treatment of minor ailments fundamentally relied on self-medication, eventually under the advice of pharmacists or other traditional healers –and not necessarily on consultations of a clinical practitioner, better documented in the medical literature.
[5] This claim reflects the Eurocentric views of the OIHP, and could be disputed: indeed, the International Sanitary Bureau (nowadays the Pan-American Health Organisation, regional office of WHO for the American continent) was established in 1902 under the International Bureau of the American Republics (nowadays Organisation of American States) –that is five years prior to the OIHP (Pan-American Health Organisation, s.d.)
[6] Renzi (1971, pp. 193-194) even presents evidence that Barrère provided personal financial support to Benito Mussolini.
[7] At the time, the Commission de l’Opium was chaired by Swiss representative Henri Carrière and integrated by the ambassadors of Egypt (Dr. Shahin Pacha), British India, and United States.
[8] Strychnine (also known as “rat poison”), arsenous acid (closely-related to arsenic), and products like sodium arsenate, potassium bromide, chloral hydrate, or zinc phosphide, are highly toxic substances, today only used as insecticides, pesticides, or products such as semiconductors.
[9] Parke-Davis had three well-established manufacturing laboratories in the USA, Canada, and the UK. This could suggest that the five preparations found in Egypt were marketed from (or via; and possibly also manufactured at) the facilities and laboratory of the company in Hounslow, UK (Hoefle, 2000 p. 31; Parke, Davis & Co., 1908, 4th cover page; Wellcome Collection, 1927). That all correspondence between the OIHP and Parke-Davis in preparation of the CEP meeting of March 1935 was undertaken either by Pr. James Gunn from London (“Obituary,” 1958) or by the representative of the UK at the OIHP (1934b; 1935, p. 162) seem to support that suggestion.
[10] Belgium, Bolivia, British India, Bulgaria, Canada, Chile, Czechoslovakia, Egypt, Ecuador, Greece, Haiti, Hungary, Irish Free State, Italy, Japan, Lettonia, Monaco, Peru, Poland, Rumania, Siam, Sudan, Turkey, Union of South Africa, Venezuela (LoN, 1937, p. 1)
[11] These cigarettes contained Belladonna leaves (0.962 g), nitrate of potash (0.033 g) and very small amounts of Cannabis extract (0.0005 g); they were produced in Paris, France (Fig. 4.D; Agence Bibliographique de l’Enseignement Supérieur, 2021; Preparations exempted…, 1951) and commercialised not only in Europe (France, Germany, Italy, Spain, UK) but as far as Siam (Preparations exempted…, 1951), New Zealand (Phillips, 2013), India (Franco-Indian Pharmaceuticals Pvt. Ltd., 2017), and the United States (Davenport, 1880); they were reportedly marketed from the 1860s (shortly after the landmark publications of O’Shaughnessy and Moreau de Tours, see Frankhauser, 2002) until the mid-20th Century.

References

  1. Agence Bibliographique de l’Enseignement Supérieur. (2021).Laboratoires Grimault (Levallois-Perret) - Identifiant IdRef : 253149169. Retrieved fromwww.idref.fr/253149169# Accessed February 22, 2022
  2. Bayer, I. & Ghodse, H. (1999). Evolution of international drug control, 1945-1995. Bulletin on Narcotics, LI(1-2) , 1–18. Available fromwww.unodc.org/pdf/bulletin_1999-01-01_1.pdf Accessed February 22, 2022
  3. Bewley-Taylor, D., Blickman, T., & Jelsma, M. (2014). The Rise and Decline of Cannabis Prohibition: the history of cannabis in the UN drug control system and options for reform. Retrieved fromhttps://www.tni.org/files/download/rise_and_decline_web.pdf Accessed February 22, 2022
  4. Bewley-Taylor, D., Jelsma, M., Rolles, S., & Walsh, J. (2016).Cannabis Regulation and the UN drug treaties: Strategies for Reform. WOLA.
  5. Boister, N. (1997). The historical development of international legal measures to suppress illicit drug trafficking. The Comparative and International Law Journal of Southern Africa, 30(1) , 1–21.
  6. Buxton, J. (2008). The historical foundations of the narcotic drug control regime. Policy Research Working Paper Series 4553 . The World Bank. Retrieved fromwww.researchgate.net/publication/23550550_The_historical_foundations_of_the_narcotic_drug_control_regime Accessed February 22, 2022
  7. Church, J., & McCaffrey, M. (2013). International organizations: available information and documentation. In: B. Reinalda (Ed.),Routledge Handbook of International Organization (pp. 27–40). Routledge.
  8. Collins, J. (2020). A Brief History of Cannabis and the Drug Conventions. AJIL Unbound 114 , 279–284.doi.org/10.1017/aju.2020.55 
  9. Collins, J. (2021). Evaluating trends and stakeholders in the international drug control regime complex. International Journal of Drug Policy, 90 , Article 103060.doi.org/10.1016/j.drugpo.2020.103060 
  10. Commission on narcotic drugs. (1955). Report on the Tenth Session, May 11, 1955. United Nations.
  11. Commission on narcotic drugs. (1960). The Question of Cannabis; Note by the Secretariat (E/CN.7/399). United Nations.
  12. Commission on narcotic drugs. (1961). List of drugs under international control, as of 25 January 1961 (E/CN.7/397/Add.2) . United Nations.
  13. Commission on narcotic drugs. (1965). The Question of Cannabis: Cannabis Bibliography - Note by the Secretary-General(E/CN.7/479) . Retrieved frombooks.google.es/books?id=xXrVsgaGD1AC Accessed February 22, 2022
  14. Commission on Narcotic Drugs. (2020). Report on the reconvened sixty-third session (2–4 December 2020); Economic and Social Council Official Records, 2020 Supplement No. 8A (E/2020/28/Add.1) . United Nations. Retrieved fromundocs.org/E/2020/28/ADD.1 Accessed February 22, 2022
  15. Csete, J. (2012). Overhauling Oversight: Human Rights at the INCB.LSE ideas: Governing the Global Drug Wars, Special Report 14 , 63–68. Retrieved fromeprints.lse.ac.uk/47122/1/Governing%20the%20global%20drug%20wars(published).pdf Accessed February 22, 2022
  16. Curran, H. V., Wiffen, P., Nutt, D. J., & Scholten, W. K. (2016).Cannabis and Cannabis Resin: Pre-Review Report; A document prepared for the World Health Organization Expert Committee on Drug Dependence Thirty-eight Meeting Geneva, 14 – 18 November 2016. Drug Science. Retrieved fromwww.drugsandalcohol.ie/26377/1/DrugSciencecannabisreport.pdf Accessed February 22, 2022
  17. Danenberg, E., Sorge, L. A., Wieniawski, W., Elliott, S., Amato, L., & Scholten, W. K. (2013). Modernizing methodology for the WHO assessment of substances for the international drug control conventions. Drug and Alcohol Dependence, 131(3), 175–181.doi.org/10.1016/j.drugalcdep.2013.02.032 
  18. Dangerous Drugs in 1946: Estimated World Requirements. (1946, March 30). Australasian Journal of Pharmacy , 174–175. Retrieved fromhttps://ajp.com.au/wp-content/uploads/2021/03/Vol027-1946-Mar-0167-0252.pdf Accessed February 22, 2022
  19. Davenport, B. F. (1880). Report on pharmaceutical preparations.Boston Medical and Surgical Journal , 103(24), 567–569. Retrieved frombabel.hathitrust.org/cgi/pt?id=pst.32239000861407&view=1up&seq=582&skin=2021 Accessed February 22, 2022
  20. Duvall, C. S. (2019). The African Roots of Marijuana. Duke University Press.
  21. Fidler, D. P. (‎2001)‎. The globalization of public health: the first 100 years of international health diplomacy. Bulletin of the World Health Organization, 79(9‎) , 842–849. Retrieved fromapps.who.int/iris/handle/10665/268428 Accessed February 22, 2022
  22. Fields of Green for All NPC. (2021). Open Letter to Secretary-General António Guterres: concerns with the ongoing development by the INCB of Guidelines related to medical cannabis. Statement submitted at the Reconvened sixty-fourth session of the Commission on Narcotic Drugs on Agenda item 5(c): Implementation of the international drug control treaties: International Narcotics Control Board. (E/CN.7/2021/NGO/7). United Nations. Retrieved fromundocs.org/E/CN.7/2021/NGO/7 Accessed February 22, 2022
  23. Franco-Indian Pharmaceuticals Pvt. Ltd. (2017). Laboratoires Griffon Pvt. Ltd. - About us. Retrieved fromwww.francoindian.com/laboratoires-griffon.htm Accessed February 22, 2022
  24. Frankhauser, M. (2002). History of Cannabis in Western Medicine. In F. Grotenhermen & E. B. Russo (Eds.), Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential (pp. 37–51). Haworth Press.
  25. Frioux, S. (2009, Novembre). Les réseaux de la modernité. Amélioration de l’environnement et diffusion de l’innovation dans la France urbaine (fin XIXe siècle - années 1950). Thèse de doctorat d’histoire, Lyon, France: Université Lumière Lyon 2. Retrived fromcore.ac.uk/download/pdf/52321499.pdf Accessed February 22, 2022
  26. Ghebali, V. Y. (1972). Aux origines de l’ECOSOC - l’évolution des commissions et organisations techniques de la Société des Nations.Annuaire Français de Droit International 18 , 469–511. Retrived fromwww.persee.fr/doc/afdi_0066-3085_1972_num_18_1_1712 Accessed February 22, 2022
  27. Grandjean. M. (2017). Structures complexes et organisations internationales : Analyses de réseaux en histoire. L’exemple de la coopération intellectuelle de la Société des Nations. Retrieved fromhalshs.archives-ouvertes.fr/halshs-01610098v2 Accessed February 22, 2022
  28. Hamilton, H. C. (1912). The Pharmacopœial requirements for Cannabis sativa. Journal of the American Pharmaceutical Association, 1(3), 200–203.doi.org/10.1002/jps.3080010304 
  29. Hoefle, M. L. (2000). The early history of Parke-Davis and Company.Bulletin for the History of Chemistry 25(1) , 28–34. Retrieved fromacshist.scs.illinois.edu/bulletin_open_access/v25-1/v25-1%20p28-34.pdf Accessed February 22, 2022
  30. Howard-Jones, N. (1950). Origins of International Health Work.British Medical Journal, 1(4661) , 1032–1037.doi.org/10.1136%2Fbmj.1.4661.1032 
  31. Howard-Jones, N. (1979). International Public Health between the Two World Wars: The Organizational Problems. History of International Public Health, 3. World Health Organization. Retrieved fromapps.who.int/iris/bitstream/handle/10665/39249/9241560584_eng.pdf Accessed February 22, 2022
  32. Huber, V. (2006). The Unification of the Globe by Disease? The International Sanitary Conferences On Cholera, 1851–1894. The Historical Journal, 49(2) , 453–476.doi.org/10.1017/S0018246X06005280 
  33. International Drug Policy Consortium. (2018). IDPC Statement at the occasion of the 40th meeting of the WHO Expert Committee on Drug Dependence, 1 June 2018. International Drug Policy Consortium. Retrieved fromfileserver.idpc.net/library/IDPC%20statement_ECDD40.pdf Accessed February 22, 2022
  34. International Narcotics Control Board. (2021a). List of Narcotic Drugs Under International Control prepared by the International Narcotics Control Board, in accordance with the Single Convention on Narcotic Drugs, 1961, and Protocol of 25 March 1972 amending the Single Convention on Narcotic Drugs, 1961 (Yellow List); 60th edition, revision 1. United Nations. Retrived fromwww.incb.org/documents/Narcotic-Drugs/Yellow_List/60th_edition/60_Yellow_List_EN_rev1.pdf Accessed February 22, 2022
  35. International Narcotics Control Board. (2021b). List of Psychotropic Substances Under International Control prepared by the International Narcotics Control Board, in accordance with the Convention on Psychotropic Substances of 1971 - 32nd edition. United Nations. Retrived fromwww.incb.org/documents/Psychotropics/forms/greenlist/2021/Green_list_ENG_V21.pdf Accessed February 22, 2022
  36. Kazatchkine, M. (2016). Preface, In H. V. Curran, P. Wiffen, D. J. Nutt, & W. K. Scholten (Eds.), Cannabis and Cannabis Resin: Pre-Review Report; A document prepared for the World Health Organization Expert Committee on Drug Dependence Thirty-eight Meeting Geneva, 14 – 18 November 2016. Drug Science. Retrieved fromwww.drugsandalcohol.ie/26377/1/DrugSciencecannabisreport.pdf Accessed February 22, 2022
  37. Kendell, R. (2003). Cannabis condemned: the proscription of Indian hemp. Addiction, 98(2) , 143–151.doi.org/10.1046/j.1360-0443.2003.00273.x 
  38. Kozma, L. (2011a). Cannabis Prohibition in Egypt, 1880–1939: From Local Ban to League of Nations Diplomacy. Middle Eastern Studies, 47(3), 443–460.doi.org/10.1080/00263206.2011.553890 
  39. Kozma, L. (2011b). The League of Nations and the debate over cannabis prohibition. History Compass, 9(1), 61–70.doi.org/10.1111/j.1478-0542.2010.00740.x 
  40. Krawitz, M. A. (2006). Parke, Davis Marketed Cannabis Extracts To Doctors With ‘Buy American’ Pitch. O’Shaughnessy’s,Spring 2006 , 4–5. Retrieved frombeyondthc.com/wp-content/uploads/2016/02/Cannabis-Americana.pdf Accessed February 22, 2022
  41. Krawitz, M. A. and Riboulet-Zemouli, K. (2018). ECDD40: Procedural, methodological and terminological bias; Joint Civil Society Contribution to the 40 th Meeting of the WHO Expert Committee on Drug Dependence. FAAAT editions. Retrieved fromarchive.org/details/ecdd40-input Accessed February 22, 2022
  42. Lande, A. (1945). Adjustment of the International Opium Administration to an Eventual Dissolution of the League of Nations. Columbia Law Review, 45(3), 392–411.doi.org/10.2307/1118580 
  43. Le Monde (1946). L’O.N.U. unifiera-t-elle l’Organisation Sanitaire Internationale ? Le Monde, March 12, 1946. Retrived fromwww.lemonde.fr/archives/article/1946/03/12/l-o-n-u-unifiera-t-elle-l-organisation-sanitaire-internationale_1872797_1819218.html Accessed February 22, 2022
  44. League of Nations. (1925). Second Opium Conference, Convention Protocol Final Act, Signed at Geneva on February 19th, 1925(C.88.M.44.1925.XI) . League of Nations.
  45. League of Nations. (1928). International Opium Convention.Treaty Series, 81 , 319. Retrieved fromtreaties.un.org/doc/Publication/UNTS/LON/Volume%2081/v81.pdf Accessed February 22, 2022
  46. League of Nations. (1933). Advisory Committee on Traffic in Opium and Dangerous Drugs. Report to the Council on the work of the Sixteenth Session, held at Geneva from May 15th to 31st, 1933 (C.385.M.193.1933.XI). League of Nations.
  47. League of Nations. (1935a). Advisory Committee on Traffic in Opium and other Dangerous Drugs. Report to the Council on the work of the Twentieth Session, held at Geneva from May 20th to June 5th, 1935 (C.253.M.125.1935.XI). League of Nations. Retrieved fromarchive.org/details/LoN1935-C.253.M.125.1935.XI Accessed February 22, 2022
  48. League of Nations (1935b). Covenant of the League of Nations, including amendments in force December 16th, 1935. Geneva, League of Nations. Retrieved fromtreaties.un.org/doc/source/covenant.pdf Accessed February 22, 2022
  49. League of Nations. (1935c). Health Organization. Report on the Twenty-second Session of the Health Committee (November 7th–14th, 1935). (C.426.M.218.1935.III). League of Nations.
  50. League of Nations. (1936). Circular Letter: Application of Article 10 of the Geneva Convention of 1925 to preparations based on Indian hemp Extract or Tincture (CL.161.1936.XI) . League of Nations.
  51. League of Nations. (1937). Health Organization. Twenty-sixth Session of the Health Committee (November 1st, 1937). Opium. Note on Preparations based on Extract or Tincture of Indian Hemp (Item 10 of the Agenda) (C.H.1278). League of Nations. Retrieved fromarchive.org/details/LoN1937-C.H.1278 Accessed February 22, 2022
  52. League of Nations. (1938a). Résolutions adoptées à la suite du rapport de la quatrième commission. In: Résolutions adoptées par l’Assemblée au cours de sa dix-neuvième session ordinaire du 12 au 30 septembre 1938 (pp. 18–23). League of Nations.
  53. League of Nations. (1938b). Application des Articles 8 et 10 de la Convention de l’Opium de 1925 : Rapport du Comité permanent de l’Office International d’Hygiène Publique concernant les préparations à base de teinture et d’extrait de chanvre indien ainsi que la désomorphine (C.H.1396) . League of Nations. Retrieved fromarchive.org/details/LoN1939-HC1396-HC1431 Accessed February 22, 2022
  54. League of Nations. (1939a). Organisation d’Hygiène. Rapport au Conseil sur les travaux de la Trentième Session du Comité d’Hygiène (Genève, 4 au 6 mai 1939) (C.136.M.87.1939.III) . League of Nations.
  55. League of Nations. (1939b). Lettre Circulaire : Application de l’Article 10 de la Convention de Genève de 1925 aux préparations à base d’Extrait ou de Teinture de chanvre indien sous réserve de certaines exemptions (C.L.99.1939.XI) . League of Nations.
  56. League of Nations. (1939c). Resolutions adopted by the Assembly, December 14th, 1939. League of Nations.
  57. League of Nations. (1939d). Revised list drawn-up by the Sub-Committee of Experts of drugs, preparations and medicines coming under The Hague (1912) and Geneva (1925) Opium Conventions and the Limitation Convention (Geneva, 1931) (C.348.M.263.1939.XI). League of Nations. Retrieved fromarchive.org/details/LoN1939-C.348.M.263.1939.XI Accessed February 22, 2022
  58. League of Nations. (1945a). Bibliographie des travaux techniques de l’Organisation d’Hygiène de la Société des Nations, 1920-1945.Bulletin de l’Organisation d’Hygiène, XI , 2–240. Retrived fromwww.who.int/library/collections/bulletin_fre.pdf Accessed February 22, 2022
  59. League of Nations. (1945b). The Committees of the League Of Nations: Classified List and Essential Facts (C.99.M.99.1945.V).League of Nations Publications Department. Retrieved frombiblio-archive.unog.ch/Dateien/CouncilMSD/C-99-M-99-1945-V_EN.pdf Accessed February 22, 2022
  60. League of Nations. (1945c). Estimated world drug requirements of Dangerous Drugs in 1946. Statement issued by the Supervisory Body under Article 5, Convention for limiting the manufacture and regulating the distribution of narcotic drugs of July 13th, 1931(C.119.M.119.1945.XI). League of Nations. Retrieved frombiblio-archive.unog.ch/Dateien/CouncilMSD/C-119-M-119-1945-XI_EN.pdf Accessed February 22, 2022
  61. League of Nations. (1946). Rapport sur les travaux de la Société pendant la Guerre, présenté à l’Assemblée par le Secrétaire général par intérim (A.6.1946). League of Nations.
  62. Ledermann, F. (2005, February 16). Bürgi, Emil; traduction Gaillard, U. In Dictionnaire historique de la Suisse. Retrived fromhls-dhs-dss.ch/fr/articles/014309/2005-02-16 Accessed February 22, 2022
  63. Leinwand, M. A. (1971). The International Law of Treaties and United States Legalization of Marijuana, Columbia Journal of Transnational Law, 10(2) , pp. 413-441. Retrieved fromheinonline.org/HOL/P?h=hein.journals/cjtl10&i=419 Accessed February 22, 2022
  64. Lin, Y.-T., & Birn, A.-E. (2021). Santé globale : des acteurs négligés, des histoires redécouvertes. monde(s) , 20,9–27.doi.org/10.3917/mond1.212.0009 
  65. LONSEA - League of Nations Search Engine. (s.d.). Dr. Ignatius Wasserberg. University of Heidelberg. Retrieved fromwww.lonsea.de/pub/person/4882 Accessed February 22, 2022
  66. Magliveras, K. D. (1999). Exclusion from Participation in International Organisations: The Law and Practice behind Member States’ Expulsion and Suspension of Membership. Martinus Nijhoff Publishers.
  67. Mathre, M., and Krawitz, M. (2002). Cannabis series ‐ the whole story Part 4: The medicinal use of Cannabis pre‐prohibition. Drugs, Habits and Social Policy, 2(2), 3–7.doi.org/10.1108/17459265200200010 
  68. May, H. L. (1948). Narcotic drug control: Development of International Action and the Establishment of Supervision under the United Nations.International Conciliation, 05(441), 302–373. Retrieved fromarchive.org/details/sim_international-conciliation_1948-05_441 Accessed February 22, 2022
  69. Mayor, S. (2019). WHO proposes rescheduling cannabis to allow medical applications. British Medical Journal, 364 , l574.doi.org/10.1136/bmj.l574 
  70. McAllister, W.B. (2000). Drug Diplomacy in the Twentieth Century. Routledge.
  71. Mechoulam, R., & Hanuš, L. (2000). A historical overview of chemical research on cannabinoids. Chemistry and Physics of Lipids, 108(1-2) , 1–13.doi.org/10.1016/s0009-3084(00)00184-5 
  72. Mikuriya, T. H. (1969). Marijuana in medicine: past, present and future. California medicine, 110(1) , 34–40.pubmed.ncbi.nlm.nih.gov/4883504 
  73. Mills, J. H. (2016). The IHO as actor : the case of cannabis and the Single Convention on Narcotic Drugs 1961. Hygiea Internationalis, 13(1) , 95–115.doi.org/10.3384/hygiea.1403-8668.1613195 
  74. Museum of Healthcare at Kingston. (2022a). Bromide and chloral compound elixir [Accession Number 000001147 a-b; Collection: Parke-Davis Collection] . Retrieved frommhc.andornot.com/en/permalink/artifact3938 Accessed February 22, 2022
  75. Museum of Healthcare at Kingston. (2022b). Indian cannabis [Accession Number: 000001051; Collection: Parke-Davis Collection] . Retrieved frommhc.andornot.com/en/permalink/artifact3519 Accessed February 22, 2022
  76. Myers, D. P. (1948). Liquidation of the League of Nations Functions.American Journal of International Law, 42(2) , 320–354.doi.org/10.2307/2193676 
  77. Obituary: J. A. Gunn, C.B.E., M.D., D.Sc., F.R.C.P. (1958).British Medical Journal 2, 1107.doi.org/10.1136/bmj.2.5104.1107
  78. Office International d’Hygiène Publique. (1925). Bulletin de l’Office International d’Hygiène Publique, 17(6) , 627–641.
  79. Office International d’Hygiène Publique. (1933). Vingt-cinq ans d’activité de l’Office International d’Hygiène Publique 1909-1933.Office International d’Hygiène Publique. Retrieved fromwww.who.int/library/collections/publique_hygiene_1909_1933.pdf Accessed February 22, 2022
  80. Office International d’Hygiène Publique. (1933b). Comité Permanent, 1ère séance, 16 octobre 1933. Office International d’Hygiène Publique.
  81. Office International d’Hygiène Publique. (1934). Comité Permanent, 1ère séance, 8 octobre 1934. Office International d’Hygiène Publique.
  82. Office International d’Hygiène Publique. (1934b). Comité Permanent, 5ème séance, 12 octobre 1934. Office International d’Hygiène Publique.
  83. Office International d’Hygiène Publique. (1935). Session extraordinaire du Comité Permanent de l’Office International d’Hygiène Publique (avril-mai 1935) : Procès verbaux des séances . Imprimerie Nationale.
  84. Office International d’Hygiène Publique. (1938). Arrangement international signé à Rome le 9 décembre 1907 pour la création, à Paris, d’un Office international d’hygiène publique. Imprimerie Nationale.
  85. Office International d’Hygiène Publique. (1939). Application des Articles 8 et 10 de la Convention de l’Opium de 1925. Rapport du Comité Permanent de l’Office International d’Hygiène Publique concernant les préparations à base de teinture et d’extrait de chanvre indien ainsi que la désomorphine. (C.H.1396). [WHO microfilm archives, Docket 1/463/4/2]
  86. Office International d’Hygiène Publique. (1949). Report of the Meeting of the Finance and Transfer Commission, Paris, December 1949.[WHO microfilm archives, Docket 956/1/15].
  87. Ottlik, G. (Ed.) (1930). Annuaire de la Société des Nations, 1930; quatrième année. Éditions de l’Annuaire.
  88. Paillette, C. (2012). Épidémies, santé et ordre mondial. Le rôle des organisations sanitaires internationales, 1903-1923. Monde(s), 2(2) , 235–256.doi.org/10.3917/mond.122.0235; retrived fromwww.cairn.info/revue-mondes1-2012-2-page-235.htm 
  89. Paillette, C. (2021). The external health action of France from 1949 to 1954. The nostalgia of influence, multilateral pragmatism and European Health Organization(s). Bulletin de l’Institut Pierre Renouvin , 52(1) , 37–45.doi.org/10.3917/bipr1.052.0037 
  90. Pan-American Health Organisation (s.d.). History of PAHO.Retrieved fromwww.paho.org/en/who-we-are/history-paho Accessed February 22, 2022
  91. Parke, Davis & Co. (1908). Cannabis Americana (Cannabis Sativa); Identical with cannabis Indica. Biological and Research Laboratories of Parke, Davis & Co. Retrieved fromarchive.org/details/parke-davis-1908-cannabis-americana Accessed February 22, 2022
  92. Parke, Davis & Co. (1911). Standardized products, a descriptive list of drug extracts standardized by chemical or physiological means, together with a list of the various forms in which these drugs are marketted. Parke, Davis & Co.
  93. Pfizer Inc. (s.d.). 2000: Pfizer joins forces with Warner-Lambert (Our purpose, History, Warner Lambert) . Retrieved fromwww.pfizer.com/about/history/pfizer_warner_lambert 
  94. Phillips, J. (2013). Drugs - Restricting drugs, 1866 to 1965. InTe Ara – the Encyclopedia of New Zealand . Retrieved fromwww.TeAra.govt.nz/en/drugs/page-2 Accessed February 22, 2022
  95. Pisanti, S., & Bifulco, M. (2017). Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back. Trends in Pharmacological Sciences, 38(3) , 195–198.doi.org/10.1016/j.tips.2016.12.002 
  96. Pietschmann, T. (2009). A century of international drug control.Bulletin on Narcotics, LIX , 1-2, 1–167.www.unodc.org/documents/data-and-analysis/bulletin/2007/Century_of_Drug_Control-E-WEB_FILE.pdf 
  97. Preparations exempted from the control measures of the Narcotics Conventions (1951). Bulletin on Narcotics, III(4) , 1–8.www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1951-01-01_4_page002.html 
  98. Principal League of Nations Documents Relating to Narcotic Drugs (1952). Bulletin on Narcotics, IV(4) , 47–76.www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1952-01-01_4_page007.html 
  99. Renborg, B. A. (1957). International Control of Narcotics. Law and Contemporary Problems, 22(1 Narcotics), 86–112. Retrieved fromhttps://scholarship.law.duke.edu/lcp/vol22/iss1/7 Accessed February 22, 2022
  100. Renzi, W. A. (1971). Mussolini’s sources of financial support, 1914-1915. History, 56 , 187, 189–206.doi.org/10.1111/j.1468-229X.1971.tb02018.x
  101. Riboulet-Zemouli, K. (2018). The Crimson Digest, volume 1, Briefing on the international scientific assessment of cannabis: processes, stakeholders and history. FAAAT editions. Retrieved fromwww.researchgate.net/publication/333825934 Accessed February 22, 2022
  102. Riboulet-Zemouli, K. (2020). ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology. Drug Science, Policy and Law, 6, Article 2050324520945797.doi.org/10.1177/2050324520945797 
  103. Rodogno, D., Gauthier, S., & Piana, F. (2013). What does transnational history tell us about a world with international organizations? In B. Reinalda (Ed.), Routledge Handbook of International Organization (pp. 94–105). Routledge.
  104. Scheerer, S. (1997). North-American Bias and Non-American Roots of Cannabis Prohibition. In L. Böllinger (Ed.), Cannabis Science: From Prohibition to Human Right (pp. 31–36). Peter Lang.
  105. Shorrock, W. I. (1975). France and the Rise of Fascism in Italy, 1919-23. Journal of Contemporary History, 10(4), 591–610.
  106. Sinha, J. (2001). The History and Development of the Leading International Drug Control Conventions (Prepared For The Senate Special Committee On Illegal Drugs) . Library of Parliament, Ottawa. Retrived fromsencanada.ca/content/sen/committee/371/ille/library/history-e.htm Accessed February 22, 2022
  107. Steffen Gerber, T. (2003). Carrière, Henri, traduction Martin, P. G.. In: Dictionnaire historique de la Suisse . Retrieved fromhls-dhs-dss.ch/fr/articles/031841/2003-08-05 Accessed February 22, 2022
  108. The cannabis problem: A note on the problem and the history of international action. (1962). Bulletin on Narcotics, XIV(4),27–31.www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1962-01-01_4_page005.html 
  109. The position of preparations of narcotic drugs under the narcotics treaties, with special reference to ‘exempted preparations.’ (1959).Bulletin on Narcotics, XI(2), 1–5.www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1959-01-01_2_page002.html 
  110. Tworek, H. J. S. (2019). Communicable Disease: Information, Health, and Globalization in the Interwar Period. The American Historical Review, 124(3), 813–842.doi.org/10.1093/ahr/rhz577 
  111. Unification of Conventions on Narcotic Drugs. (1950). Bulletin on Narcotics, II(2), 33–54.www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1950-01-01_2_page006.html 
  112. United Nations. (s.d.). The history of multilateralism in controlling pandemics. Retrieved fromwww.un.org/node/111918Accessed February 22, 2022
  113. United Nations Office on Drugs and Crime. (2008). A Century of International Drug Control: The Development of the Legal Framework and Codification of the International Control System. United Nations. Retrieved fromwww.unodc.org/documents/data-and-analysis/Studies/100_Years_of_Drug_Control.pdf Accessed February 22, 2022
  114. United Nations Relief and Rehabilitation Administration. (1943).Office International D’Hygiene Publique, Paris (Item S-1271-0000-0173-00001) . Retrieved fromsearch.archives.un.org/office-international-dhygiene-publique-paris-2 Accessed February 22, 2022
  115. Waetjen, T. (2018). How cannabis became a ‘drug’ in South Africa.Points: Joint Blog of the Alcohol & Drugs History Society and the American Institute of the History of Pharmacy. Retrieved frompointshistory.com/2018/07/10/how-cannabis-became-a-drug-in-south-africa/ Accessed February 22, 2022
  116. Wasserberg, I. (1935). Correspondence between I. Wasserberg and Dr Gautier, dated 27 March 1935. [League of Nations Archives, Docket 12/17411/6043]. Retrieved fromarchive.org/details/lon1935-docket-12.17411.6043 Accessed February 22, 2022
  117. Wellcome Collection. (1927). King’s College (London) medical students visiting the Parke, Davis & Co. Laboratories, Hounslow . Retrieved fromwellcomecollection.org/works/rd75exw4/items?langCode=eng&canvas=1 Accessed February 22, 2022
  118. World Health Organisation. (1947a). Expert Committee on the Unification of Pharmacopoeias; Fourth Meeting, held on Tuesday, 14 October 1947 at 2.15 p.m., Palais des Nations . World Health Organisation. [WHO microfilm archives, Docket 758/4/1]
  119. World Health Organisation. (1947b). Report of the Committee of Legal Experts on the Responsibilities of the Interim Commission with Respect to the Narcotics Conventions; Fourth Session (WHO.IC/110) . World Health Organisation. [WHO microfilm archives, Docket 758/4/1]
  120. World Health Organisation. (1948a). Executive Board, Third Session. Situation with regard to the denunciation of the agreement creating the Office International d’Hygiene Publique (EB3/18) . World Health Organisation. Retrieved fromapps.who.int/iris/bitstream/handle/10665/113035/EB3_18_eng.pdf Accessed February 22, 2022
  121. World Health Organisation. (1948b). Interim Commission - Performance by the WHO of certain duties and functions in respect of narcotic drugs – General correspondence. World Health Organisation. [WHO microfilm archives, Docket 463/1/1].
  122. World Health Organisation. (1950a). Memorandum submitted by the Director-General: The position as regards the Office International d’Hygiene Publique (Provisional Agenda, Item A.F. & L.25)(A3/46, A3/46 Add.1, and A3/46 Add.1 Rev.1). World Health Organisation. Retrieved fromapps.who.int/iris/bitstream/handle/10665/99855/WHA3_46_eng.pdf Accessed February 22, 2022
  123. World Health Organisation. (‎1950b)‎. WHA resolution 3.98: Office International d’Hygiène Publique. In Official Records of the World Health Organization No. 42 . World Health Organisation. Retrieved fromapps.who.int/iris/handle/10665/85607 Accessed February 22, 2022
  124. World Health Organisation. (‎1952a)‎. WHA resolution 5.40, Office International d’Hygiène Publique : Denunciation of Rome Agreement by the Federal Republic of Germany, Japan and Spain. In Official Records of the World Health Organization No. 42 . Retrieved fromapps.who.int/iris/handle/10665/85641 Accessed February 22, 2022
  125. World Health Organisation. (‎1952b)‎. Expert Committee on Drugs Liable to Produce Addiction; Third Report. [WHO Technical Report Series No. 57].apps.who.int/iris/bitstream/handle/10665/40195/WHO_TRS_57.pdf Accessed February 22, 2022
  126. World Health Organisation. (1958). The first ten years of the World Health Organization. World Health Organisation. Retrieved fromapps.who.int/iris/bitstream/handle/10665/37089/a38153_eng_HR.pdf Accessed February 22, 2022
  127. World Health Organisation. (2014). Cannabis and cannabis resin: Information Document [Agenda item 8.2]; WHO Expert Committee on Drug Dependence, 36th Meeting, Geneva, 16-20 June 2014. Geneva: WHO.www.who.int/medicines/areas/quality_safety/8_2_Cannabis.pdf Accessed February 22, 2022
  128. World Health Organisation. (2018). Role of the WHO under International Drug Control Conventions. WHO Newsroom. Retrived from www.who.int/news-room/commentaries/detail/role-of-the-WHO-under-international-drug-control-conventions Accessed February 22, 2022
  129. Zuardi, A. W. (2006). History of cannabis as a medicine: a review [História da cannabis como medicamento: uma revisão]. Brazilian Journal of Psychiatry, 28(2), 153–157. doi.org/10.1590/S1516-44462006000200015